These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3762014)

  • 1. Pharmacokinetics and dynamics of penbutolol in humans: evidence for pathway-specific stereoselective clearance.
    Ochs HR; Hajdú P; Greenblatt DJ
    Klin Wochenschr; 1986 Jul; 64(14):636-41. PubMed ID: 3762014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Modification of myocardial function parameters by L- and D-penbutolol--an echocardiography, placebo-controlled double-blind study].
    Grube E; Herzog H; Lüderitz B
    Z Kardiol; 1985 Feb; 74(2):99-105. PubMed ID: 3993154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of penbutolol and its metabolites in renal insufficiency.
    Bernard N; Cuisinaud G; Pozet N; Zech PY; Sassard J
    Eur J Clin Pharmacol; 1985; 29(2):215-9. PubMed ID: 4076321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of penbutolol on lidocaine kinetics.
    Ochs HR; Skanderra D; Abernethy DR; Greenblatt DJ
    Arzneimittelforschung; 1983; 33(12):1680-1. PubMed ID: 6686773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative beta-adrenoceptor blocking effects and pharmacokinetics of penbutolol and propranolol in man.
    Giudicelli JF; Richer C; Chauvin M; Idrissi N; Berdeaux A
    Br J Clin Pharmacol; 1977 Apr; 4(2):135-40. PubMed ID: 16632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single and divided doses of penbutolol.
    Müller FO; Hundt HK; Bromley PA; Torres J; Vanderbeke O
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):528-35. PubMed ID: 436357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penbutolol and propranolol: a comparison of their effects on antipyrine clearance in man.
    Bax ND; Jones RW; Lennard MS; Tucker GT; Woods HF
    Br J Clin Pharmacol; 1985 May; 19(5):593-6. PubMed ID: 4005101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penbutolol: beta-adrenoceptor interaction and the time course of plasma concentrations explain its prolonged duration of action in man.
    Wellstein A; Palm D
    Eur J Clin Pharmacol; 1985; 29(3):293-300. PubMed ID: 3000796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penbutolol Pharmacokinetics: the influence of concomitant administration of cimetidine.
    Spahn H; Kirch W; Hajdu P; Mutschler E; Ohnhaus EE
    Eur J Clin Pharmacol; 1986; 29(5):555-60. PubMed ID: 3956561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic and pharmacokinetic study of oral and intravenous penbutolol.
    Vedin JA; Wilhelmsson C; Maass L; Peterson LE
    Eur J Clin Pharmacol; 1983; 25(4):529-34. PubMed ID: 6653649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma protein binding of penbutolol in pregnancy.
    Aquirre C; Rodriguez-Sasiain JM; Navajas P; Calvo R
    Eur J Drug Metab Pharmacokinet; 1988; 13(1):23-6. PubMed ID: 3396610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein binding studies of furosemide and penbutolol.
    Gottschalk R; Sistovaris N
    Arzneimittelforschung; 1985; 35(6):899-902. PubMed ID: 4026914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of penbutolol and 4-hydroxypenbutolol in plasma or serum by HPLC.
    Bhamra RK; Flanagan RJ; Holt DW
    Biomed Chromatogr; 1986 Jun; 1(3):140-2. PubMed ID: 3506824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of penbutolol and its hydroxylated metabolite in biological fluids by reversed-phase high-performance liquid chromatography.
    Bernard N; Cuisinaud G; Sassard J
    J Chromatogr; 1982 Mar; 228():355-61. PubMed ID: 7076761
    [No Abstract]   [Full Text] [Related]  

  • 15. Penbutolol (Hoe 893d) in primary hypertension. Blood pressure effects, tolerance and plasma concentrations.
    Ohman KP; Asplund J; Landahl S; Liander B
    Eur J Clin Pharmacol; 1982; 22(2):95-9. PubMed ID: 7047173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma level profiles and clinical response of penbutolol after three different single oral doses in man.
    Jun HW; Hayes SL; Vallner JJ; Honigberg IL; Rojos AE; Stewart JT
    J Clin Pharmacol; 1979; 19(8-9 Pt 1):415-23. PubMed ID: 489760
    [No Abstract]   [Full Text] [Related]  

  • 17. Penbutolol: pharmacokinetics, effect on exercise tachycardia, and in vitro inhibition of radioligand binding.
    Brockmeier D; Hajdù P; Henke W; Mutschler E; Palm D; Rupp W; Spahn H; Verho MT; Wellstein A
    Eur J Clin Pharmacol; 1988; 35(6):613-23. PubMed ID: 2906875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of single doses of penbutolol and propranolol L.A. on psychomotor performance.
    Broadhurst AD; Monaghan AT
    Br J Clin Pharmacol; 1984 May; 17(5):591-4. PubMed ID: 6733006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Extent of beta-blocking action of S- and R-penbutolol during exercise testing (author's transl)].
    Kober G; Schulz W; Hermann HJ; Kaltenbach M
    Z Kardiol; 1982 Apr; 71(4):289-94. PubMed ID: 6283753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of piretanide tablets, penbutolol tablets and the fixed combination of both drugs in healthy male subjects after a single oral dose.
    Müller F; Meyer B; Grigoleit HG
    Int J Clin Pharmacol Res; 1987; 7(6):469-75. PubMed ID: 3440637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.